The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
Open accessAbstract
BACKGROUND: Despite recent discoveries of new molecular targets and pathways, the search for an effective therapy for Glioblastoma Multiforme (GBM) continues. A newly emerged field, radiogenomics, links gene expression profiles with MRI phenotypes. MRI-FLAIR is a noninvasive diagnostic modality and was previously found to correlate with cellular invasion in GBM. Thus, our radiogenomic screen has the potential to reveal novel molecular determinants of invasion. Here, we present the first comprehensive radiogenomic analysis using quantitative MRI volumetrics and large-scale gene- and microRNA expression profiling in GBM. METHODS: Based on The Cancer Genome Atlas (TCGA), discovery and validation sets with gene, microRNA, and quantitative MR-imaging data were created. Top concordant genes and microRNAs correlated with high FLAIR volumes from both sets were further characterized by Kaplan Meier survival statistics, microRNA-gene correlation analyses, and GBM molecular subtype-specific distribution. RESULTS: The top upregulated gene in both the discovery (4 fold) and validation (11 fold) sets was PERIOSTIN (POSTN). The top downregulated microRNA in both sets was miR-219, which is predicted to bind to POSTN. Kaplan Meier analysis demonstrated that above median expression of POSTN resulted in significantly decreased survival and shorter time to disease progression (P<0.001). High POSTN and low miR-219 expression were significantly associated with the mesenchymal GBM subtype (P<0.0001). CONCLUSION: Here, we propose a novel diagnostic method to screen for molecular cancer subtypes and genomic correlates of cellular invasion. Our findings also have potential therapeutic significance since successful molecular inhibition of invasion will improve therapy and patient survival in GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Dweep, H., Sticht, C., Pandey, P., & Gretz, N. (2011) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.05.002 · Cited by 1,696
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Cited by
MicroRNA: Function, Detection, and Bioanalysis
Dong, H., Lei, J., Ding, L., Wen, Y., Ju, H., & Zhang, X. (2013) · Chemical Reviews · doi:10.1021/cr300362f · Cited by 1,224
Limkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review
Aerts, H. J. W. L. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2631 · Cited by 669
Castel, D., Philippe, C., Calmon, R., Le Dret, L., Truffaux, N., Boddaert, N., Pagès, M., Taylor, K. R., Saulnier, P., Lacroix, L., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1478-0 · Cited by 664
Li, Y. M., Suki, D., Hess, K., & Sawaya, R. (2016) · Journal of Neurosurgery · doi:10.3171/2015.5.jns142087 · Cited by 646
Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation
Parmar, C., Rios Velazquez, E., Leijenaar, R., Jermoumi, M., Carvalho, S., Mak, R. H., Mitra, S., Shankar, B. U., Kikinis, R., Haibe-Kains, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102107 · Cited by 611
Joint and individual variation explained (JIVE) for integrated analysis of multiple data types
Lock, E. F., Hoadley, K. A., Marron, J. S., & Nobel, A. B. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas597 · Cited by 552
Reproducibility of radiomics for deciphering tumor phenotype with imaging
Zhao, B., Tan, Y., Tsai, W.-Y., Qi, J., Xie, C., Lu, L., & Schwartz, L. H. (2016) · Scientific Reports · doi:10.1038/srep23428 · Cited by 509
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
Ellingson, B. M., Wen, P. Y., & Cloughesy, T. F. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0507-6 · Cited by 476
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
Parmar, C., Leijenaar, R. T. H., Grossmann, P., Rios Velazquez, E., Bussink, J., Rietveld, D., Rietbergen, M. M., Haibe-Kains, B., Lambin, P., & Aerts, H. J. W. L. (2015) · Scientific Reports · doi:10.1038/srep11044 · Cited by 434
Gutman, D. A., Cooper, L. A. D., Hwang, S. N., Holder, C. A., Gao, J., Aurora, T. D., Dunn, W. D., Scarpace, L., Mikkelsen, T., Jain, R., et al. (2013) · Radiology · doi:10.1148/radiol.13120118 · Cited by 420
Self-citationZhou, M., Scott, J., Chaudhury, B., Hall, L., Goldgof, D., Yeom, K. W., Iv, M., Ou, Y., Kalpathy-Cramer, J., Napel, S., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5391 · Cited by 415
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology
Wu, W., Parmar, C., Grossmann, P., Quackenbush, J., Lambin, P., Bussink, J., Mak, R., & Aerts, H. J. W. L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00071 · Cited by 378
Bady, P., Sciuscio, D., Diserens, A.-C., Bloch, J., van den Bent, M. J., Marosi, C., Dietrich, P.-Y., Weller, M., Mariani, L., Heppner, F. L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1016-2 · Cited by 344
Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features
Gevaert, O., Mitchell, L. A., Achrol, A. S., Xu, J., Echegaray, S., Steinberg, G. K., Cheshier, S. H., Napel, S., Zaharchuk, G., & Plevritis, S. K. (2014) · Radiology · doi:10.1148/radiol.14131731 · Cited by 319
Radiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
“[37] PERIOSTIN Correlative Volumetric – FLAIR volumes MRI”
BackgroundKickingereder, P., Bonekamp, D., Nowosielski, M., Kratz, A., Sill, M., Burth, S., Wick, A., Eidel, O., Schlemmer, H.-P., Radbruch, A., et al. (2016) · Radiology · doi:10.1148/radiol.2016161382 · Cited by 305
Macyszyn, L., Akbari, H., Pisapia, J. M., Da, X., Attiah, M., Pigrish, V., Bi, Y., Pal, S., Davuluri, R. V., Roccograndi, L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov127 · Cited by 301
Radiogenomics: What It Is and Why It Is Important
Mazurowski, M. A. (2015) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2015.04.019 · Cited by 290
Spatiotemporal genomic architecture informs precision oncology in glioblastoma
Lee, J.-K., Wang, J., Sa, J. K., Ladewig, E., Lee, H.-O., Lee, I.-H., Kang, H. J., Rosenbloom, D. S., Camara, P. G., Liu, Z., et al. (2017) · Nature Genetics · doi:10.1038/ng.3806 · Cited by 273
Itakura, H., Achrol, A. S., Mitchell, L. A., Loya, J. J., Liu, T., Westbroek, E. M., Feroze, A. H., Rodriguez, S., Echegaray, S., Azad, T. D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7582 · Cited by 272
Karlo, C. A., Di Paolo, P. L., Chaim, J., Hakimi, A. A., Ostrovnaya, I., Russo, P., Hricak, H., Motzer, R., Hsieh, J. J., & Akin, O. (2014) · Radiology · doi:10.1148/radiol.13130663 · Cited by 270
Tumor Cell Invasion in Glioblastoma
Vollmann-Zwerenz, A., Leidgens, V., Feliciello, G., Klein, C. A., & Hau, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061932 · Cited by 257
Predictive radiogenomics modeling of EGFR mutation status in lung cancer
Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., Shrager, J. B., Jensen, K. C., Berry, G. J., Guo, H. H., Lau, C., Plevritis, S. K., et al. (2017) · Scientific Reports · doi:10.1038/srep41674 · Cited by 160
Elshafeey, N., Kotrotsou, A., Hassan, A., Elshafei, N., Hassan, I., Ahmed, S., Abrol, S., Agarwal, A., El Salek, K., Bergamaschi, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11007-0 · Cited by 147
Self-citationQuantitative imaging to evaluate malignant potential of IPMNs
Hanania, A. N., Bantis, L. E., Feng, Z., Wang, H., Tamm, E. P., Katz, M. H., Maitra, A., & Koay, E. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11769 · Cited by 143
Ellingson, B. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0506-0 · Cited by 132
Zhou, M., Hall, L., Goldgof, D., Russo, R., Balagurunathan, Y., Gillies, R., & Gatenby, R. (2014) · Translational Oncology · doi:10.1593/tlo.13730 · Cited by 97
Role of imaging in the era of precision medicine
Giardino, A., Gupta, S., Olson, E., Sepulveda, K., Lenchik, L., Ivanidze, J., Rakow-Penner, R., Patel, M. J., Subramaniam, R. M., & Ganeshan, D. (2017) · Academic Radiology · doi:10.1016/j.acra.2016.11.021 · Cited by 87
Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
“[207, 208], [209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219], [220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231].”
Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
Panayides, A. S., Pattichis, M. S., Leandrou, S., Pitris, C., Constantinidou, A., & Pattichis, C. S. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2879381 · Cited by 66
Rathore, S., Bakas, S., Pati, S., Akbari, H., Kalarot, R., Sridharan, P., Rozycki, M., Bergman, M., Tunc, B., Verma, R., et al. (2018) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-75238-9_12 · Cited by 57
Jalalifar, S. A., Soliman, H., Sahgal, A., & Sadeghi-Naini, A. (2022) · Cancers · doi:10.3390/cancers14205133 · Cited by 15
Metadata
- Authors
- Zinn, P. O., Majadan, B., Sathyan, P., Singh, S. K., Majumder, S., Jolesz, F. A., & Colen, R. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-05
- Volume
- 6
- Issue
- 10
- Pages
- e25451
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1969604869
- Cited by
- 265
- References
- 46
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.